Cite
HARVARD Citation
Horby, P. et al. (2021). Tocilizumab in COVID-19 therapy: who benefits, and how? – Authors' reply. Lancet. 398 (10297), pp. 300-. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Horby, P. et al. (2021). Tocilizumab in COVID-19 therapy: who benefits, and how? – Authors' reply. Lancet. 398 (10297), pp. 300-. [Online].